Charlotte's Web Holdings (CWBHF) Depreciation & Amortization (CF) (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Depreciation & Amortization (CF) came in at $1.7 million in Q1 2026, down 31.48% year-on-year from $2.4 million in Q1 2025, and little changed on a QoQ basis from $1.7 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.7 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 31.48% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 44.12% decrease from a year earlier, with the FY2025 full-year figure at $6.3 million, down 36.64% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for CWBHF reached as high as $4.0 million in Q2 2023 and fell as low as $512000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $2.5 million across 5 years, with a median of $2.5 million in 2024.
- Across the five-year window, Depreciation & Amortization (CF) soared 113.59% in 2023 and sank 79.43% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $3.2 million in 2022, then increased by 13.88% to $3.7 million in 2023, then plunged by 32.24% to $2.5 million in 2024, then tumbled by 32.38% to $1.7 million in 2025, then increased by 0.3% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 512,000.00 |
| Jun 30, 2025 | 512,000.00 |
| Mar 31, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Sep 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 3.65 Mn |
| Dec 31, 2023 | 3.65 Mn |